Karbonisasi Limbah Biomassa Ampas Sagu Sebagai Bahan Baku Bioenergi
Wahana Forestra: Jurnal Kehutanan · 2026
DOI: 10.31849/81x7c184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Wahana Forestra: Jurnal Kehutanan, 2026. Verfasst von Rina Novia Yanti und 2 weiteren Autor:innen.
Abstract (Originalsprache)
One source of biomass raw material is the sago plant (Metroroxylon sp). Sago (Metroroxylon sp) is vegetation that can produce starch to be used as a food source. Unt il now, sago tree processing waste, especially sago dregs, has not been utilized optimally and only a small portion is used as feed, especially for ruminants. Apart from that, sago dregs are dumped in shelters or along river flows at sago processing locations which results in environmental pollution. Because sago bark waste is biomass waste, it can potentially be used as raw material for bioenergy such as biopellets, biobriquettes, charcoal. The aim of the research is to look at the physical and chemical characteristics of raw materials. The method used refers to the Indonesian National Standard 01-6235 of 2000. The results obtained from this research are the physical properties, namely water content 11.3%, ash content 4.3%, volatile matter content 2.4% and calorific value 6,430 cal. /gram. Meanwhile, the chemical properties analyzed by GCMS contained 18.93% hydrocarbon compounds. Phenol compounds 57.4 %, Benzene compounds 11.41 %
Zitieren
APA
Yanti, R. N., Yelmiza, & Purnamasari, R. (2026). Karbonisasi Limbah Biomassa Ampas Sagu Sebagai Bahan Baku Bioenergi. Wahana Forestra: Jurnal Kehutanan. https://doi.org/10.31849/81x7c184
Vancouver
Yanti RN, Yelmiza, Purnamasari R. Karbonisasi Limbah Biomassa Ampas Sagu Sebagai Bahan Baku Bioenergi. Wahana Forestra: Jurnal Kehutanan. 2026. doi:10.31849/81x7c184
BibTeX
@article{Yanti2026,
author = {Yanti, Rina Novia and Yelmiza and Purnamasari, Reni},
title = {Karbonisasi Limbah Biomassa Ampas Sagu Sebagai Bahan Baku Bioenergi},
journal = {Wahana Forestra: Jurnal Kehutanan},
year = {2026},
doi = {10.31849/81x7c184}
}
EUVIMED